Pakistan reports new polio case in northwest, raising 2025 tally to 12
KARACHI: Pakistan's polio eradication program on Friday said a new wild poliovirus case had been detected in the country's northwestern Khyber Pakhtunkhwa province, bringing the total tally of 2025 cases to 12.
Polio is a paralyzing disease with no cure, making prevention through vaccination critical. Multiple doses of the oral polio vaccine, along with the completion of the routine immunization schedule for all children, are essential to build strong immunity against the virus.
The country conducted three nationwide vaccination campaigns in February, April and May, aiming to immunize around 45 million children across Pakistan with the support of over 400,000 frontline workers including 225,000 women vaccinators.
'The Regional Reference Laboratory for Polio Eradication at the National Institute of Health, Islamabad, has confirmed a new case of wild poliovirus in District Bannu, South Khyber Pakhtunkhwa,' the body said in a statement.
'The 33-month-old male child from Union Council Shamsikhel, District Bannu is the sixth case of polio reported from Khyber Pakhtunkhwa this year.'
Pakistan has reported 12 polio cases so far this year, including six from Khyber Pakhtunkhwa, four from the southern Sindh province and one each from the populous Punjab province and the northern Gilgit-Baltistan region.
Pakistan, one of the last two countries where polio remains endemic along with Afghanistan, has made significant progress in curbing the virus, with annual cases dropping from around 20,000 in the early 1990s to just eight in 2018.
However, the country reported an alarmingly high number of 74 cases in 2024, after six in 2023 and only one in 2021.
Health Minister Mustafa Kamal on Thursday claimed that Pakistan has recorded a 99 percent decline in polio cases, as he urged global vaccine organization Gavi to invest more in efforts to 'train and retain' vaccinators.
Pakistan launched its polio eradication program in 1994, but its efforts have repeatedly been hindered by widespread vaccine misinformation and resistance from hard-line religious groups who claim immunization campaigns are a Western conspiracy to sterilize Muslim children or a front for espionage.
Militant groups have also targeted polio workers and police officials providing them security, often with deadly attacks that have hampered vaccination drives, particularly in the country's remote and conflict-prone regions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
37 minutes ago
- Al Arabiya
The new generation of blockbuster weight-loss drugs, explained
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few years, though they do have some drawbacks. After France on Friday became the latest country to allow all doctors—rather than just specialists—to prescribe these drugs, here are some key questions about them. How do they work? The most well-known of this new wave of drugs are Danish pharma firm Novo Nordisk's Ozempic and Wegovy, as well as US company Eli Lilly's Mounjaro. These drugs enhance the action of a hormone in the pancreas called 'glucagon-like peptide 1,' or GLP-1, the name given to this family of medications. The hormone affects the secretion of insulin, so it was first targeted to develop drugs to combat diabetes. But it turned out that GLP-1 drugs also suppress people's appetite by making them feel fuller. A revolution? Obesity experts now agree that these drugs are a historic breakthrough in the history of people trying to lose weight. Previously, surgery was the main option for obesity when diet and exercise did not work. This is no small feat. Obesity affects 900 million people worldwide, in what is considered a major crisis. The new drugs 'cover a major unmet need: obesity was one of the only chronic diseases for which there were few medications,' French endocrinologist Emmanuel Disse told AFP. During clinical trials, the drugs have been found to reduce people's weight by an average of 15 to 20 percent. Limitations? However, these drugs do have some limitations, including side effects. The semaglutide drug used in Ozempic has been approved for diabetes since 2017, so there is now nearly a decade of research on its use. A large study using health data from hundreds of thousands of US veterans published in January found that GLP-1s are not linked to a higher risk of heart problems or suicidal thoughts, as had previously been suggested. However, there are rare cases of serious side effects, such as damage to the pancreas, it said. More commonly, they can also cause nausea, vomiting, migraines and disturb sleep, which can turn some patients off the drugs. They also do not work for everyone—some people taking the drugs do not lose weight. And the effect only lasts when people are taking the drug, meaning that they potentially need lifelong treatment. They are also expensive, sometimes costing over $1,000 a month in the United States to 300 euros ($340) in France. The drugs are also only available in injectable forms—though pharma firms are developing daily pills that have shown promise in early trials. Who should use them? National health agencies have emphasized that these drugs should only be prescribed to overweight or obese people for whom things like exercise and diet have failed. However, there is plenty of evidence that some people who are not overweight use the drugs simply to lose a few extra kilos. France's ANSM medications authority said that these drugs should 'not be used for weight loss for aesthetic purposes,' warning that inappropriate use could expose people to 'adverse effects that are sometimes serious.' What next? Steven O'Rahilly, head of Cambridge University's Institute of Metabolic Sciences, told AFP he was confident there will be 'a pretty rapid evolution of drugs that are more effective, with fewer side effects, cheaper and more convenient.' 'It may be more of a challenge to combine all those four advances in a single medicine,' he added. With billions of dollars at stake, pharma firms are racing to be the first to market with a new treatment. Novo Nordisk's experimental drug amycretin could be even more effective than existing GLP-1s, according to early trial results published in The Lancet on Saturday. There has also been a growing field of research revealing the potential benefits of GLP-1 drugs beyond obesity. They have been linked to improvements for a range of maladies, including dementia and addiction. It is still unclear if these are a direct effect of the drugs or are linked to improvements with obesity or diabetes.
Arab News
11 hours ago
- Arab News
Pakistan reports new polio case in northwest, raising 2025 tally to 12
KARACHI: Pakistan's polio eradication program on Friday said a new wild poliovirus case had been detected in the country's northwestern Khyber Pakhtunkhwa province, bringing the total tally of 2025 cases to 12. Polio is a paralyzing disease with no cure, making prevention through vaccination critical. Multiple doses of the oral polio vaccine, along with the completion of the routine immunization schedule for all children, are essential to build strong immunity against the virus. The country conducted three nationwide vaccination campaigns in February, April and May, aiming to immunize around 45 million children across Pakistan with the support of over 400,000 frontline workers including 225,000 women vaccinators. 'The Regional Reference Laboratory for Polio Eradication at the National Institute of Health, Islamabad, has confirmed a new case of wild poliovirus in District Bannu, South Khyber Pakhtunkhwa,' the body said in a statement. 'The 33-month-old male child from Union Council Shamsikhel, District Bannu is the sixth case of polio reported from Khyber Pakhtunkhwa this year.' Pakistan has reported 12 polio cases so far this year, including six from Khyber Pakhtunkhwa, four from the southern Sindh province and one each from the populous Punjab province and the northern Gilgit-Baltistan region. Pakistan, one of the last two countries where polio remains endemic along with Afghanistan, has made significant progress in curbing the virus, with annual cases dropping from around 20,000 in the early 1990s to just eight in 2018. However, the country reported an alarmingly high number of 74 cases in 2024, after six in 2023 and only one in 2021. Health Minister Mustafa Kamal on Thursday claimed that Pakistan has recorded a 99 percent decline in polio cases, as he urged global vaccine organization Gavi to invest more in efforts to 'train and retain' vaccinators. Pakistan launched its polio eradication program in 1994, but its efforts have repeatedly been hindered by widespread vaccine misinformation and resistance from hard-line religious groups who claim immunization campaigns are a Western conspiracy to sterilize Muslim children or a front for espionage. Militant groups have also targeted polio workers and police officials providing them security, often with deadly attacks that have hampered vaccination drives, particularly in the country's remote and conflict-prone regions.
Arab News
15 hours ago
- Arab News
Health officials issue warnings as UK bakes in the first heat wave of 2025
LONDON: British health officials are warning people across the country to take precautions when out in the sun as the UK bakes under its first heat wave of the year. Temperatures are expected to peak at 34 degrees Celsius (93 degrees Fahrenheit) in some parts of eastern England on Saturday following a week of unusually warm weather, according to the national weather agency the Met Office. That's about 12 C (22 F) higher than normal for this time of year. The UK Health Security Agency has issued an amber heat health alert covering all of England because of increased health risks for people over 65 and those with heart and lung problems. 'Heat can result in serious health outcomes across the population, especially for older adults or those with pre-existing health conditions,' Dr. Agostinho Sousa, head of the UKHSA, said in a statement. 'It is therefore important to check on friends, family and neighbors who are more vulnerable and to take sensible precautions while enjoying the sun.' Saturday is expected to be the hottest day of the heat wave, with temperatures falling slightly on Sunday and dropping back into the more normal temperatures next week, the Met Office said. The heat alert is currently scheduled to remain in effect until Monday morning. Unusually, temperatures in London this week have been higher than in many parts of Western Europe. That's because the high temperatures are not the result of hot air moving north from the Iberian Peninsula or North Africa as is often the case, the Met Office said. Instead, this weather system originated in air high over the Atlantic Ocean south of Greenland. As it approaches the UK, it descends toward ground level, causing it to warm rapidly, Chief Meteorologist Matthew Lenhert said. That said, it has been plenty hot in Europe too. Aviation enthusiasts attending the Paris Air Show in Le Bourget, north of Paris, this week sought the shade of a Boeing 777's wing, cooling off as temperatures hovered in the low 30s C (mid-80s F.) Met Office scientists this week published research showing that climate change is increasing the likelihood of extreme high temperatures in the UK The chance of temperatures exceeding 40 C (104 F) is now more than 20 times higher than it was in the 1960s, the researchers said.
